Commonwealth of Pennsylvania Public School Empls Retrmt SYS Acquires New Shares in Kenvue Inc. (NYSE:KVUE)

Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new stake in Kenvue Inc. (NYSE:KVUEFree Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 346,521 shares of the company’s stock, valued at approximately $6,958,000.

Several other large investors have also recently added to or reduced their stakes in KVUE. Clearstead Advisors LLC bought a new stake in shares of Kenvue in the 3rd quarter valued at approximately $25,000. Kistler Tiffany Companies LLC bought a new stake in shares of Kenvue in the 2nd quarter valued at approximately $26,000. Tamarack Advisers LP bought a new stake in shares of Kenvue in the 2nd quarter valued at approximately $26,000. AdvisorNet Financial Inc bought a new stake in shares of Kenvue in the 3rd quarter valued at approximately $28,000. Finally, Global Retirement Partners LLC bought a new stake in shares of Kenvue in the 3rd quarter valued at approximately $28,000. Institutional investors and hedge funds own 11.33% of the company’s stock.

Kenvue Price Performance

Shares of KVUE opened at $19.33 on Friday. The company has a current ratio of 1.14, a quick ratio of 0.78 and a debt-to-equity ratio of 0.71. The business’s fifty day moving average price is $20.96 and its two-hundred day moving average price is $21.06. Kenvue Inc. has a 52 week low of $17.82 and a 52 week high of $27.80.

Kenvue (NYSE:KVUEGet Free Report) last announced its quarterly earnings data on Thursday, February 8th. The company reported $0.31 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.03. The firm had revenue of $3.67 billion for the quarter, compared to analyst estimates of $3.78 billion. Kenvue had a return on equity of 14.83% and a net margin of 9.87%. The firm’s revenue was down 2.7% compared to the same quarter last year. As a group, equities analysts forecast that Kenvue Inc. will post 1.19 EPS for the current year.

Kenvue Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, February 28th. Stockholders of record on Wednesday, February 14th will be paid a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.14%. The ex-dividend date of this dividend is Tuesday, February 13th.

Analysts Set New Price Targets

KVUE has been the topic of several analyst reports. Piper Sandler initiated coverage on Kenvue in a research note on Friday, November 17th. They issued a “neutral” rating and a $20.00 price objective on the stock. JPMorgan Chase & Co. decreased their price target on Kenvue from $25.00 to $24.00 and set an “overweight” rating on the stock in a research report on Friday. UBS Group increased their price target on Kenvue from $20.00 to $23.00 and gave the stock a “neutral” rating in a research report on Tuesday, December 19th. Finally, Royal Bank of Canada decreased their price target on Kenvue from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday. Six research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $25.92.

Get Our Latest Stock Analysis on Kenvue

Kenvue Profile

(Free Report)

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands.

Featured Stories

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUEFree Report).

Institutional Ownership by Quarter for Kenvue (NYSE:KVUE)

Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.